InnovAge appears to be in the early stages of a fundamental turnaround, driven by a reacceleration in revenue growth to 20.1% in Q4 2026 following the lifting of enrollment freezes, which has finally translated into positive operating income of $16.0 million. ...
Price trend, volume and key moving averages
Trailing total returns as of 10/3/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Sep 8, 2026 | $0.06-19.6% vs $0.07 | $262M+9.9% vs $238M |
Q2 2026 May 5, 2026 | -$0.22-466.7% vs $0.06 | $252M+7.5% vs $234M |
Q1 2026 Feb 3, 2026 | $0.08+100.0% vs $0.04 | $240M+5.0% vs $228M |
Q4 2025 Nov 4, 2025 | $0.06+500.0% vs $0.01 | $236M+4.2% vs $226M |
Shares of InnovAge Holding Corp. (NASDAQ: INNV - Get Free Report) saw an uptick in trading volume on Monday. Approximately 187,524 shares changed hands during trading, a decline of 46% from the previous session's volume of 345,752 shares. The stock last traded at $9.0760 and had previously closed at $9.00. Analyst Upgrades and Downgrades Several research
PACS Group (NYSE: PACS - Get Free Report) and InnovAge (NASDAQ: INNV - Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, profitability, valuation and earnings. Profitability This table compares PACS Group and InnovAge's net
DENVER, Sept. 22, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced the pricing of an underwritten public offering of 10,000,000 shares of its common stock by investment funds affiliated with Apax Partners and Welsh, Carson, Anderson & Stowe (together, the “Selling Stockholders”) at a price to the public of $9.25 per share.
DENVER, Sept. 22, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced the launch of an underwritten public offering of its common stock by investment funds affiliated with Apax Partners and Welsh, Carson, Anderson & Stowe (together, the “Selling Stockholders”).
Benchmark INNV against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for InnovAge Holding Corp. (INNV)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $8.80 | $1.19B | -40.00 | 11.76% | -3.55% | -10.77% | — | |
| $7.74 | $1.6B | -2091.89 | 46.06% | 0.89% | 20.02% | — | |
| $29.90 | $7.75B | -17.69 | 27.5% | 3.6% | 38.45% | — | |
| $169.63 | $9.89B | 29.05 | 18.72% | 6.9% | 16.51% | — | |
| $13.25 | $428.06M | -4.52 | -21.56% | -9.84% | -27.1% | — | |
| $365.20 | $331.65B | 27.60 | 11.81% | 3.14% | 13.49% | — |
InnovAge Holding Corp. (INNV) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
InnovAge Holding Corp. (INNV) SEC filings — annual & quarterly reports (10-K, 10-Q)
Sep 8, 2026·SEC
May 5, 2026·SEC
Mar 17, 2026·SEC
Get notified when INNV posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
InnovAge Holding Corp. (INNV) stock FAQ — growth, dividends, profitability & financials explained
InnovAge Holding Corp. (INNV) reported $989.7M in revenue for fiscal year 2025. This represents a 113% increase from $465.6M in 2019.
InnovAge Holding Corp. (INNV) grew revenue by 11.8% over the past year. This is steady growth.
InnovAge Holding Corp. (INNV) reported a net loss of $2.5M for fiscal year 2025.
InnovAge Holding Corp. (INNV) has a return on equity (ROE) of -10.8%. Negative ROE indicates the company is unprofitable.
InnovAge Holding Corp. (INNV) generated $50.4M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
